城建發展(600266.SH):擬公開掛牌轉讓北科建9.24%股權
格隆匯6月5日丨城建發展(600266.SH)公佈,截止公告日,北科建註冊資本爲30.29億元,公司持有北科建2.8億股,約佔其總股本的9.24%。公司擬通過北京產權交易所公開掛牌轉讓持有的北科建9.24%股權(以下簡稱“交易標的”),掛牌價格不低於北科建淨資產評估值乘以公司持股比例,即2.82億元(最終以經國資備案的資產評估報告結果爲準),最終交易價格及交易對方以在北京產權交易所公開掛牌成交結果爲準。
爲優化公司資產結構和資源配置,盤活存量資產,提升運營效率,公司擬轉讓所持北科建股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.